Polycystic Ovary Syndrome clinical trials at UCSF
2 in progress, 1 open to eligible people
Saroglitazar Magnesium 4 mg in the Treatment of NAFLD in Women With PCOS (EVIDENCES VII)
open to eligible females ages 18-45
This is a multicenter, phase 2A, randomized, double-blind, placebo-controlled study designed to evaluate the efficacy and safety of Saroglitazar Magnesium in women with well characterized PCOS.
San Francisco, California and other locations
PCOS & Insulin Resistance Exercise Study
Sorry, in progress, not accepting new patients
This study evaluates the feasibility and metabolic effects of implementing a structured exercise program in women with polycystic ovary syndrome and insulin resistance. Participants will be randomized to either 75 minutes of vigorous exercise or 150 minutes of moderate exercise per week.
San Francisco, California
Our lead scientists for Polycystic Ovary Syndrome research studies include Dr. Monika Sarkar Heather Huddleston.
Last updated: